Erythrophobia: understanding the fear of blushing in public

Erythrophobia is an anxiety disorder characterised by an intense and irrational fear of blushing in the presence of others. This French term, derived from the Greek ereuthros (red) and phobos (fear), appears in clinical dictionaries as a specific form of social phobia. It differs from ordinary, normal blushing: everyone blushes, but a person with erythrophobia fears blushing to the point of organising their life around avoiding it.

This fear of fear lies at the heart of the disorder. The individual anticipates blushing even before the social situation arises, triggering anticipatory anxiety that, paradoxically, promotes the very blushing they fear.

The DSM-5[1] diagnostic criteria allow a diagnosis of social anxiety disorder (SAD), under which erythrophobia falls:

• Persistent fear of one or more social situations in which the person might be observed
• Fear of acting in a humiliating way or displaying visible symptoms of anxiety (such as blushing)
• Exposure that almost invariably provokes anxiety in the feared situation
• Active avoidance or enduring the situation with marked distress
• Duration of at least 6 months
• Significant functional impairment in social, professional or personal relationships

Without these duration and impairment criteria, this is considered shyness or ordinary social discomfort, rather than a clinical disorder.

Specific phobias have a lifetime prevalence of 5 to 15 %[2] in the general population, depending on the study. Erythrophobia, as a social phobia, falls within this range. Psychiatrist Antoine Pelissolo describes it as “much more common than people think”.

The sex ratio is clear: across all phobias, there are more than 2 women for every 1 man[2]. Erythrophobia follows this general pattern.

The age of onset varies according to the type of phobia. Situational phobias have two peaks: the first in childhood, the second after the age of 20. Erythrophobia, which is linked to social interactions, often follows this pattern, frequently emerging in adolescence or early adulthood, a period when how others see us becomes central.

One counterintuitive point deserves attention: contrary to popular belief, situational phobias increase with age and remain widespread among older people[2]. Erythrophobia does not disappear spontaneously over time. Without treatment, it tends to become chronic.

Blushing is a normal reaction of the autonomic nervous system. In erythrophobia, this reaction escalates and creates an anxiety loop that sustains the disorder.

The role of the autonomic nervous system

Blushing is an involuntary response of the sympathetic nervous system. In response to an emotion or a situation perceived as threatening, the brain releases adrenaline. This hormone causes vasodilation of the facial capillaries: the blood vessels dilate, blood flow increases, and the skin of the face and neck takes on a pink or red hue.

This mechanism is universal and is not pathological in itself. In a person with erythrophobia, the activation threshold is lower: merely anticipating a social situation is enough to activate the adrenergic cascade, even in the absence of any real danger.

The negative loop: anxiety and blushing

The vicious circle of erythrophobia works as follows: the fear of blushing generates anticipatory anxiety, which activates the sympathetic nervous system, which causes the feared blushing, which reinforces the belief that the situation is dangerous.

The amygdala, a brain structure involved in processing fear, plays a central role: it detects the social threat and raises the alarm. The prefrontal cortex, normally responsible for modulating this response, struggles to “switch off” the signal in anxiety disorders. As a result, the physiological reaction escalates before the situation even occurs, making avoidance increasingly difficult to overcome.

Erythrophobia results from a combination of genetic, neurobiological and environmental factors. No single cause has been identified.

Genetic and hereditary factors

A genetic predisposition is likely. Clinical observations show that erythrophobia and social phobias frequently occur within the same family across several generations. This hereditary transmission suggests that some individuals are born with a more reactive autonomic nervous system and a lower threshold for sympathetic activation.

Care must be taken not to confuse predisposition with determinism. Having a parent with erythrophobia does not mean that a person will develop the disorder: genetics creates vulnerability, not inevitability.

Psychological and environmental factors

The environment plays an equally decisive role. A humiliating experience in public (being mocked for visible blushing, being put in a difficult position when speaking) can be a triggering event. The disorder can also develop through social learning: observing a parent who is anxious in social situations, or growing up in a family or cultural context that places great value on emotional control.

These environmental factors interact with biological vulnerability. It is their combination that, in some cases, leads to the development of clinically significant erythrophobia.

The manifestations of erythrophobia fall into three distinct, often overlapping categories.

Physical symptoms:

• Visible blushing of the face, neck or upper chest
• An intense sensation of heat
• Increased sweating
• Heart palpitations
• Trembling or a breaking voice

Cognitive symptoms:

• Catastrophic thoughts (“Everyone is looking at me”, “I’m going to look ridiculous”)
• Hypervigilance to other people’s reactions
• Rumination after social situations
• A belief that the blushing is far more visible than it really is

Avoidance behaviours:

• Refusing to speak in meetings or in class
• Avoiding eye contact
• Escaping group situations or shared meals
• Choosing clothing that covers the skin to conceal blushing

The functional impairment can be considerable. At work, the person turns down promotions that involve public presentations. Socially, they gradually withdraw from interactions. In their personal life, romantic relationships or friendships become less frequent.

Without treatment, this systematic avoidance of social situations can lead to progressive isolation and comorbidities: major depression or alcohol abuse, with alcohol often used as a short-term social disinhibitor but worsening the disorder in the long term[1].

Several therapeutic approaches have demonstrated their effectiveness. The choice depends on the severity of the disorder and any comorbidities present.

Cognitive behavioural therapies

Cognitive behavioural therapies are recommended[1] as first-line treatment, with Grade A evidence. Their effectiveness relies on two complementary mechanisms.

First, cognitive restructuring: identifying and challenging irrational beliefs (“I am not good enough”, “I will be rejected”) and replacing them with more realistic thoughts. Next, gradual exposure: gradually confronting the patient with feared situations, from the least anxiety-provoking to the most difficult, until anxiety decreases naturally. Participation in assertiveness training groups is also recommended at Grade A.

For practitioners who wish to incorporate exposure into their practice without logistical constraints, therapeutic virtual reality environments make it possible to recreate graded, controlled social situations (public speaking, group interaction) that can be adjusted in real time. C2Care offers this approach to more than 700 trained practitioners across 350 institutions.

Medication

In severe cases, medication may be combined with psychotherapy. Four drugs have marketing authorisation for the treatment of social phobia[1]: sertraline, paroxetine, escitalopram and venlafaxine (serotonin reuptake inhibitors or serotonin–noradrenaline reuptake inhibitors).

Non-cardioselective beta-blockers (propranolol) are used as a one-off dose before an anxiety-provoking situation to reduce cardiovascular symptoms. They do not address the underlying disorder.

For mild to moderate specific phobias, there is no medication that is effective in the long term: psychotherapy remains the central approach.

Complementary approaches

Some approaches support the main treatments. Relaxation and techniques for regulating the autonomic nervous system help reduce sympathetic activation. Hypnotherapy, combined with CBT, produces satisfactory results in several anxiety disorders. Regular exercise carries a Grade C recommendation under the clinical guidelines[1]. When an alcohol-related comorbidity is present, its management takes priority.

Key points about erythrophobia

Erythrophobia is a common anxiety disorder, potentially affecting 5 to 15% of the population. Its origins are multifactorial: genetic, neurobiological and environmental. It is more than shyness and does not disappear without intervention.

CBT is the first-line treatment, with demonstrated effectiveness. In severe cases, medication may be added. Consulting a healthcare professional as soon as the disorder affects daily life remains the most appropriate step. With early treatment, the course is generally favourable.